Jiro Minami
Minato, 1058461, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Correction: Dual Inhibition of Canonical and Noncanonical NF-κB Pathways Demonstrates Significant Antitumor Activities in Multiple Myeloma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 03, 2019
Successful allogeneic peripheral blood stem cell transplantation for an aggressive variant of T-cell large granular-lymphocyte leukemia: A case report.
Journal: Blood cell therapy
Published: May 20, 2018
Clinical significance of cancer-related fatigue in multiple myeloma patients.
Journal: International journal of hematology
Published: January 17, 2018
Epstein-Barr Virus-associated Lymphoproliferative Disorder with Encephalitis Following Anti-thymocyte Globulin for Aplastic Anemia Resolved with Rituximab Therapy: A Case Report and Literature Review.
Journal: Internal medicine (Tokyo, Japan)
Published: March 22, 2017
Lysozyme in breast milk is a selection factor for bifidobacterial colonisation in the infant intestine.
Journal: Beneficial microbes
Published: October 28, 2015
Combination of a Selective HSP90α/β Inhibitor and a RAS-RAF-MEK-ERK Signaling Pathway Inhibitor Triggers Synergistic Cytotoxicity in Multiple Myeloma Cells.
Journal: PloS one
Published: June 08, 2015
Selective and potent Akt inhibition triggers anti-myeloma activities and enhances fatal endoplasmic reticulum stress induced by proteasome inhibition.
Journal: Cancer research
Published: June 18, 2014
Histone deacetylase 3 as a novel therapeutic target in multiple myeloma.
Journal: Leukemia
Published: April 03, 2013
Dual inhibition of canonical and noncanonical NF-κB pathways demonstrates significant antitumor activities in multiple myeloma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 19, 2012
Last Updated: 09/26/2026